Workflow
Beijing Fjr Optoelectronic Technology(688272)
icon
Search documents
*ST富吉:关于注销武汉分公司的公告
2023-08-24 08:36
证券代码:688272 证券简称:*ST 富吉 公告编号:2023-047 北京富吉瑞光电科技股份有限公司 关于注销武汉分公司的公告 注册地址:湖北省武汉市东湖新技术开发区关东街道茅店村博瀚科技光电子 信息产业基地二期 2 栋 B 单元 3 层 1 号房-8 负责人:李宜斌 成立日期:2022-08-16 营业期限:2022-08-16 至 无固定期限 经营范围:一般项目:电子产品销售;智能仪器仪表制造;电气信号设备装 置制造;电子专用设备制造;集成电路设计;人工智能应用软件开发;技术服务、 技术开发、技术咨询、技术交流、技术转让、技术推广(除许可业务外,可自主 依法经营法律法规非禁止或限制的项目) 二、董事会会议审议情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 根据北京富吉瑞光电科技股份有限公司(以下简称"公司")整体经营规划, 为优化企业组织架构,提高公司管理效率,公司拟注销北京富吉瑞光电科技股份 有限公司武汉分公司,并授权公司经营管理层办理本次分公司注销相关事宜。具 体情况如下: 一、拟注销分公司的基本情况 ...
*ST富吉:第二届监事会第二次会议决议公告
2023-08-24 08:36
证券代码:688272 证券简称:*ST 富吉 公告编号:2023-045 北京富吉瑞光电科技股份有限公司 第二届监事会第二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 表决结果:同意 3 票,反对 0 票,弃权 0 票;本议案获得通过。 2、审议通过《关于<2023 年半年度募集资金存放与使用情况的专项报告> 的议案》 监事会认为:公司 2023 年半年度募集资金存放与实际使用情况符合《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》《上海证 券交易所科创板上市公司自律监管规则适用指引第 1 号——规范运作》等相关 法律法规的要求,公司对募集资金进行了专户存储,不存在变相改变募集资金 用途的情形,不存在损害股东利益的情形,也不存在募集资金使用违反相关法 律法规的情形。 一、监事会会议召开情况 北京富吉瑞光电科技股份有限公司(以下简称"公司")第二届监事会第 二次会议于 2023 年 8 月 24 日在公司会议室以现场结合通讯的方式召开,公司 于 2023 年 8 月 14 日以邮件 ...
*ST富吉:关于2023年半年度计提资产及信用减值准备的公告
2023-08-24 08:34
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 北京富吉瑞光电科技股份有限公司(以下简称"富吉瑞"或"公司")于 2023 年 8 月 24 日召开第二届董事会第二次会议及第二届监事会第二次会议,会 议审议通过了《关于公司 2023 年半年度计提资产及信用减值准备的议案》,该 议案无需提交股东大会审议,现将具体情况公告如下: 一、计提减值准备情况概述 根据《企业会计准则》及公司制度的相关规定,为了真实、准确地反映公 司 2023 年半年度的财务状况和经营成果,基于谨慎性原则,公司对截至 2023 年 6 月 30 日合并报表范围内可能发生资产及信用减值损失的有关资产及信用计 提资产减值准备。 2023 年半年度,公司计提资产减值损失 1,638.54 万元,计提信用减值损失- 1,159.27 万元,具体如下表: 单位:万元 证券代码:688272 证券简称:*ST 富吉 公告编号:2023-048 北京富吉瑞光电科技股份有限公司 关于 2023 年半年度计提资产及信用减值准备的公告 二、计提减值准备事项的具体说明 (一) ...
*ST富吉:关于2023年半年度募集资金存放与实际使用情况的专项报告
2023-08-24 08:34
证券代码:688272 证券简称:*ST 富吉 公告编号:2023-046 北京富吉瑞光电科技股份有限公司 关于 2023 年半年度募集资金存放与使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 (一)实际募集资金金额和资金到账时间 经中国证券监督管理委员会《关于同意北京富吉瑞光电科技股份有限公司首 次公开发行股票注册的批复》(证监许可[2021]2820 号)核准,北京富吉瑞光 电科技股份有限公司(以下简称"富吉瑞"或"公司")于 2021 年 10 月 18 日 向社会首次公开发行人民币普通股(A 股)1,900 万股,每股发行价为 22.56 元, 募集资金总额为人民币 428,640,000.00 元,根据有关规定扣除发行费用 58,801,633.67 元后,实际募集资金金额为 369,838,366.33 元。该募集资金已 于 2021 年 10 月 13 日全部到账。容诚会计师事务所(特殊普通合伙)对公司本 次公开发行新股的资金到位情况进行了审验,并于 2021 年 1 ...
*ST富吉:关于召开2023年半年度业绩说明会的公告
2023-08-24 08:34
证券代码:688272 证券简称:*ST 富吉 公告编号:2023-050 北京富吉瑞光电科技股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 会议召开时间:2023 年 9 月 1 日(星期五) 下午 16:00-17:00 会议召开地点:上海证券交易所上证路演中心(网址:https://roads how.sseinfo.com/) 会议召开方式:上证路演中心网络互动 投资者可于 2023 年 8 月 25 日(星期五) 至 8 月 31 日(星期四)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 fujirui@ fjroe.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 北京富吉瑞光电科技股份有限公司(以下简称"公司")已于 2023 年 8 月 25 日发布公司 2023 年半年度报告,为便于广大投资者更全面深入地了解公司 2023 年半年度经营成果、财务状况,公司计划于 2023 年 9 月 ...
*ST富吉(688272) - 2022 Q4 - 年度财报
2023-06-13 16:00
Financial Performance - In 2022, the company's operating revenue decreased significantly from 144.0681 million yuan to 110.8911 million yuan, with a net profit attributable to shareholders of the parent company at -87.6414 million yuan[4]. - The company's net profit after deducting non-recurring gains and losses also showed a loss, indicating a challenging financial year due to slow order signing and delivery progress[4]. - The company is at risk of delisting as its audited net profit was negative and operating revenue fell below 100 million yuan, which violates the Shanghai Stock Exchange's listing rules[4]. - The proposed profit distribution plan for 2022 is to not distribute profits or increase capital reserves due to the financial losses incurred[6]. - The company's operating revenue for 2022 was ¥110,891,094.70, a decrease of 65.12% compared to ¥317,927,242.89 in 2021[21]. - The net profit attributable to shareholders was -¥87,641,440.52, representing a decline of 214.65% from ¥76,443,601.71 in the previous year[21]. - The net profit after deducting non-recurring gains and losses was -¥93,194,847.19, down 241.19% from ¥66,005,689.75 in 2021[21]. - The company's total assets decreased by 5.82% to ¥748,961,427.23 from ¥795,255,000.45 in 2021[21]. - The basic earnings per share for 2022 was -¥1.15, a drop of 190.55% from ¥1.27 in 2021[22]. - The weighted average return on net assets was -13.90%, a decrease of 36.91 percentage points from 23.01% in 2021[22]. - The decline in revenue was attributed to economic downturns and delays in military procurement plans, leading to reduced order demand[23]. - The net cash flow from operating activities was -¥97,385,180.55, compared to -¥86,239,617.32 in 2021[21]. - The gross profit margin dropped from 52.69% in 2021 to 31.90% in 2022, indicating increased cost pressures and market competition[129]. - The company reported a significant decrease in financing cash flow, down 96.00% to 14,273,581.46 RMB, primarily due to last year's fundraising activities[156]. Research and Development - Research and development expenses accounted for 43.68% of operating revenue, an increase of 31.59 percentage points from 12.09% in 2021[22]. - The company increased R&D investments to explore new product markets and actively participated in military project bidding, resulting in higher expenses[23]. - R&D expenses amounted to 48.43 million yuan, accounting for 43.68% of operating revenue, with a year-on-year increase of 25.99%[34]. - The company added 8 new patents and 1 new software copyright in 2022, bringing the total to 70 effective authorized patents[34]. - The company has developed core technologies for the infrared panoramic radar, including the high-precision rotating platform and intelligent alarm technology[50]. - The company has developed multiple core technologies in the field of infrared thermal imaging, achieving key performance indicators that are at or near international advanced levels[70]. - The company has developed a new generation of vehicle auxiliary driving night vision imaging technology, integrating uncooled infrared thermal imaging sensors and low-light solid-state micro-light sensors for multi-spectral imaging capabilities[80]. - The company has filed for 20 new patents during the reporting period, including 5 invention patents and 8 utility model patents[83]. - The company is focusing on the development of advanced algorithms to improve image clarity and performance, addressing the increasing demands for automation in target detection and recognition[75]. Market and Competitive Position - The company aims to stabilize supply channels and reverse competitive trends in the context of declining prices for downstream products[32]. - The infrared thermal imaging industry is experiencing rapid growth, with increasing applications in both military and civilian sectors due to advancements in technology and decreasing costs[59]. - The company is positioned in a rapidly developing industry, with a significant reduction in reliance on imported products due to the rise of domestic infrared enterprises[60]. - The military market for infrared thermal imaging products is substantial, with high demand for reliability and performance, particularly in developed countries[60]. - The domestic civil infrared thermal imaging market is projected to reach $4.113 billion in 2023, with a compound annual growth rate (CAGR) of approximately 18.61% from 2020 to 2023[63]. - The company is actively expanding its presence in the civil market, focusing on applications in industrial temperature measurement, gas detection, and security monitoring[69]. - The company is committed to innovation through integrated technology, enhancing its product offerings in both military and civil sectors[69]. - The company is focused on expanding its market presence through new product development and technological advancements, targeting various applications including airborne, marine, and automotive sectors[93][94][96]. Governance and Compliance - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties, ensuring compliance with regulations[8]. - The company has not violated decision-making procedures for external guarantees, maintaining governance integrity[8]. - The financial report received a standard unqualified audit opinion from the accounting firm, indicating reliability in the financial statements[5]. - The company emphasizes the importance of rational investment and risk awareness in its forward-looking statements regarding future plans and strategies[7]. - The company has established an internal control system to enhance risk prevention capabilities and operational standards in accordance with national requirements[183]. - The company has complied with all relevant regulations regarding information disclosure, ensuring transparency and accuracy[177]. - There were no significant differences in corporate governance compared to the regulations set by the China Securities Regulatory Commission[178]. Operational Challenges - The company faces various operational risks, including a significant decline in performance and potential delisting risks, which investors should be particularly aware of[4]. - The company relies on external procurement for key components such as detectors and high-end lenses, which poses a supply chain risk[125]. - The company faces risks related to supplier relationships, particularly for critical components like detectors and lenses, which could impact production and costs[126]. - The company is actively working to optimize its talent management and recruitment strategies to mitigate risks associated with talent shortages as it expands[127]. - The company is focusing on integrating infrared and visible light sensors to improve the functionality of its handheld observation instruments[102]. Investment and Future Plans - The company aims to enhance its imaging technology by expanding into solid-state micro-light, short-wave, ultraviolet, and visible light areas over the next three to five years[168]. - The company plans to deepen its focus on military and professional markets to increase market share and brand awareness[170]. - The company intends to invest more resources in research and development to create products suitable for civilian and general markets, ensuring competitive advantages[170]. - The company will establish a professional R&D team and strengthen collaborations with academic and research institutions to improve R&D efficiency[170]. - The company plans to complete the development of an 8-10 km laser rangefinder, with a total investment of 350.00 million CNY and 170.09 million CNY invested so far[91].
*ST富吉:关于召开2022年度暨2023年第一季度业绩暨现金分红说明会的公告
2023-05-10 08:18
关于召开 2022 年度暨 2023 年第一季度业绩暨现金分红说 明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 会议召开时间:2023 年 5 月 19 日(星期五) 下午 13:00-14:00 证券代码:688272 证券简称:富吉瑞 公告编号:2023-030 北京富吉瑞光电科技股份有限公司 会议召开地点:上海证券交易所上证路演中心 (网址:http://roadsh ow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 投资者可于 2023 年 5 月 12 日(星期五) 至 5 月 18 日(星期四)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 fujirui@fjroe.com 进行提问。公司将在业绩说明会上对投资者普遍关注的问题 进行回答。 北京富吉瑞光电科技股份有限公司(以下简称"公司")已于 2023 年 4 月 26 日发布公司 2022 年度报告及 2023 年第一季度报告,为便于广大投资者更全面深 入地了解公司 2022 ...
*ST富吉(688272) - 2023 Q1 - 季度财报
2023-04-25 16:00
Financial Performance - The company's revenue for Q1 2023 was CNY 30,906,365.17, representing a year-on-year increase of 107.45% compared to CNY 14,489,830 in the same period last year[5] - Total operating revenue for Q1 2023 was CNY 30,906,365.17, a 106.5% increase from CNY 14,898,298.41 in Q1 2022[23] - The net profit attributable to shareholders was -CNY 19,130,116.53, a decrease of CNY 2,428,500 compared to -CNY 16,701,616.53 in the previous year[7] - Net loss for Q1 2023 was CNY 19,130,116.53, compared to a net loss of CNY 16,701,589.96 in Q1 2022, indicating a worsening of 8.5%[24] - Basic and diluted earnings per share for Q1 2023 were both CNY -0.25, compared to CNY -0.22 in Q1 2022[25] Cost and Margin Analysis - The gross margin for the period was 20.30%, down 17.05 percentage points from 37.35% in the same period last year, primarily due to rising raw material costs and increased industry competition[7] - Total operating costs for Q1 2023 were CNY 56,311,222.53, up 69.7% from CNY 33,168,539.51 in Q1 2022[23] Research and Development - Research and development expenses totaled CNY 16,587,867.03, an increase of 73.89% from CNY 9,539,500 in the previous year, reflecting the company's commitment to increasing R&D investment[6] - The company reported a decrease in the proportion of R&D expenses to revenue, which was 53.67%, down 10.36 percentage points from the previous year[6] - Research and development expenses increased to CNY 16,587,867.03 in Q1 2023, compared to CNY 9,539,480.27 in Q1 2022, reflecting a 74.0% rise[23] Cash Flow and Liquidity - The net cash flow from operating activities was -CNY 11,298,293.25, with no applicable year-on-year comparison due to negative cash flow[5] - The company’s cash flow from operating activities showed a significant increase, reflecting improved operational efficiency and revenue generation[27] - The net cash flow from operating activities was -$11,298,293.25, a significant improvement from -$29,936,972.15 in the previous year[28] - Total cash inflow from operating activities was $66,885,297.42, while cash outflow was $78,183,590.67[28] - Cash received from sales of goods and services in Q1 2023 was CNY 63,891,562.00, significantly up from CNY 22,693,983.66 in Q1 2022, marking an increase of 182.5%[27] Assets and Liabilities - The total assets at the end of the reporting period were CNY 713,789,049.74, a decrease of 4.70% from CNY 748,961,427.23 at the end of the previous year[6] - The total current assets as of March 31, 2023, amounted to ¥655,103,183.25, a decrease of approximately 6.5% from ¥700,408,831.38 on December 31, 2022[18] - Total liabilities decreased to CNY 149,115,907.17 in Q1 2023 from CNY 165,158,168.13 in Q1 2022, a reduction of 9.7%[20] - Total equity decreased to CNY 564,673,142.57 in Q1 2023 from CNY 583,803,259.10 in Q1 2022, a decline of 3.3%[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,034[13] - The company reported a total of 10 major shareholders, with significant holdings by Ningbo Ruijifu Technology Center (Limited Partnership) and others[15] Government Support - The company received government subsidies amounting to CNY 901,000.00 during the reporting period[9] Future Outlook - The company has not disclosed any significant new product developments or market expansion strategies during the reporting period[16] - The company has not provided specific future guidance or performance outlook in the current report[16]
*ST富吉(688272) - 2022 Q4 - 年度财报
2023-04-25 16:00
Financial Performance - In 2022, the company's operating revenue decreased significantly to CNY 110.89 million, down from CNY 144.07 million, representing a decline of approximately 23.4%[4] - The net profit attributable to shareholders of the listed company was CNY -87.64 million, indicating a loss compared to the previous year[6] - The company reported a net profit of CNY -85.37 million for the parent company, reflecting ongoing financial challenges[6] - The company's operating revenue for 2022 was ¥110,891,094.70, a decrease of 65.12% compared to ¥317,927,242.89 in 2021[21] - The net profit attributable to shareholders was -¥87,641,440.52, representing a decline of 214.65% from ¥76,443,601.71 in the previous year[21] - The net profit after deducting non-recurring gains and losses was -¥93,194,847.19, down 241.19% from ¥66,005,689.75 in 2021[21] - The company's total assets decreased by 5.82% to ¥748,961,427.23 from ¥795,255,000.45 in 2021[21] - The basic earnings per share for 2022 was -¥1.15, a drop of 190.55% from ¥1.27 in 2021[22] - The decline in revenue was attributed to economic downturns and delays in military procurement plans, leading to reduced order demand[23] - The company reported a significant decrease in net cash flow from financing activities, down 96.00% to 14,273,581.46 RMB, primarily due to last year's fundraising[162] Operational Risks - The company is at risk of delisting due to negative net profit and operating revenue below CNY 100 million, as per the Shanghai Stock Exchange regulations[4] - The company faces risks related to significant performance declines due to slow order signing and delivery progress, exacerbated by military procurement procedures and economic downturns[4] - The company has outlined various risks in its operations, including the potential for further financial losses in 2023 if current trends continue[4] - The company is facing risks related to quality control as it scales operations and introduces new products, necessitating continuous improvement in quality management[126] - The company is exposed to risks from international trade policies, particularly U.S. export controls, which could impact its supply chain and operational capabilities[131] Research and Development - Research and development expenses accounted for 43.68% of operating revenue, an increase of 31.59 percentage points from 12.09% in 2021[22] - The company increased R&D investments to explore new product markets and actively participated in military project bidding, resulting in higher expenses[23] - The company achieved a total R&D investment of ¥48,433,053.47 in 2022, representing a 25.99% increase compared to ¥38,442,411.38 in the previous year[85] - R&D investment accounted for 43.68% of the company's operating revenue, a significant increase of 31.59 percentage points from 12.09% in the previous year[85] - The company has developed multiple core technologies in the field of infrared thermal imaging, achieving key performance indicators that are at or near international advanced levels[70] Market Position and Strategy - The company aims to enhance its core technology by integrating upstream supply chains and developing non-cooling infrared detectors to stabilize supply channels and improve overall product gross margins[32] - The company is focused on infrared thermal imaging products while navigating a challenging economic environment and competitive market[32] - The company aims to position itself as a quality supplier for state-owned military enterprises, leveraging its strengths in infrared thermal imaging technology[69] - The company is actively expanding its presence in the civil market, focusing on applications in industrial temperature measurement, gas detection, and security monitoring[69] - The company plans to deepen its focus on military and professional markets to increase market share and brand awareness[178] Product Development and Innovation - The company has developed a new generation of vehicle auxiliary driving night vision imaging technology, integrating uncooled infrared thermal imaging sensors and low-light solid-state micro-light sensors for multi-spectral imaging capabilities[80] - The company has developed advanced optical design technologies that reduce the number of optical lenses required while maintaining imaging quality[79] - The company has developed a low-power large-area infrared detector driving technology, significantly reducing overall power consumption[77] - The company is developing a multi-spectral electro-optical pod with a total investment of $396.40 million, having invested $186.93 million in the current period and $187.72 million cumulatively, aimed at high-precision target tracking and positioning[93] - The company has successfully developed non-cooled cores with resolutions of 1024×768 and 1280×1024, with the former being one of the first handheld industrial thermal imaging devices in China to reach 1K resolution[73] Governance and Management - The board of directors held a total of 12 meetings during the reporting period, with 9 members including 3 independent directors[183] - The supervisory board convened 8 meetings in 2022, consisting of 3 supervisors, complying with legal and regulatory requirements[184] - The company established an internal control system to enhance risk prevention capabilities and operational standards[185] - The company’s governance structure complies with relevant laws and regulations, with no significant discrepancies noted[186] - The company has a diverse executive team with significant experience in technology and management, enhancing its strategic capabilities[194] Market Trends and Industry Insights - The infrared thermal imaging industry is experiencing rapid growth, with increasing applications in both military and civilian sectors due to advancements in technology and decreasing costs[59] - The domestic civil infrared thermal imaging market is projected to reach $4.113 billion in 2023, with a compound annual growth rate (CAGR) of approximately 18.61% from 2020 to 2023[63] - The growth of the civil infrared market is driven by technological advancements that reduce the costs of uncooled infrared thermal imagers, expanding their applications in various sectors[62] - The Chinese military infrared thermal imaging market is experiencing rapid growth due to the acceleration of national defense modernization, with a focus on enhancing weaponry and strategic deterrence capabilities[62] - The company is committed to innovation through integrated technology, enhancing its product offerings in both military and civil sectors[69]
*ST富吉(688272) - 2022 Q3 - 季度财报
2022-10-26 16:00
Financial Performance - The company's operating revenue for Q3 2022 was ¥20,214,207.40, a decrease of 70.86% compared to the same period last year[5] - The net profit attributable to shareholders was -¥20,853,603.38, reflecting a decline of 227.39% year-over-year[5] - The net profit excluding non-recurring gains and losses for the period was -¥21,429,053.75, down 235.71% from the previous year[5] - The company reported a net loss of RMB 64.10 million for the third quarter of 2022, with a net profit attributable to shareholders of RMB -68.83 million after deducting non-recurring gains and losses[14] - Total operating revenue for the first nine months of 2022 was RMB 48.06 million, highlighting a significant financial challenge[14] - Total revenue for the first three quarters of 2022 was CNY 48,059,634.49, a significant decrease from CNY 223,610,136.45 in the same period of 2021[21] - Net profit for the third quarter of 2022 was a loss of CNY 64,098,321.06, compared to a profit of CNY 47,473,424.99 in the same quarter of 2021[22] - The total comprehensive income attributable to the parent company for Q3 2022 was -64,098,321.06 RMB, compared to 47,473,424.99 RMB in the same period last year[23] Research and Development - The total R&D investment for the quarter was ¥12,303,733.40, an increase of 91.21% year-over-year, representing 60.87% of operating revenue[6] - Research and development expenses increased to CNY 40,762,820.98 in the first three quarters of 2022, up from CNY 25,352,107.67 in 2021[21] - The company plans to continue increasing R&D investment to explore new product markets and enhance product diversity[10] - The company is focusing on market expansion and new product development to improve future performance[21] - The company plans to enhance its technological capabilities through increased investment in R&D[21] Cash Flow and Liquidity - The cash flow from operating activities for the year-to-date was -¥77,145,919.39, indicating a significant decrease in sales collections[6] - Cash and cash equivalents as of September 30, 2022, were RMB 309.84 million, down from RMB 374.25 million at the end of 2021[17] - Net cash flow from operating activities for the first nine months of 2022 was -77,145,919.39 RMB, compared to -53,947,022.48 RMB in the same period last year[26] - Cash inflow from operating activities totaled 79,174,119.05 RMB for the first nine months of 2022, while cash outflow was 156,320,038.44 RMB[26] - Cash flow from investing activities for the first nine months of 2022 resulted in a net outflow of -615,630.54 RMB[27] - Cash flow from financing activities generated a net inflow of 13,348,777.86 RMB in the first nine months of 2022, compared to a net outflow of -16,506,109.87 RMB in the same period last year[27] - The ending cash and cash equivalents balance as of Q3 2022 was 309,840,994.01 RMB, down from 374,253,766.08 RMB at the beginning of the period[27] - The company received 50,580,000.00 RMB from borrowings in Q3 2022, compared to 20,000,000.00 RMB in the same period last year[27] - The company paid 20,000,000.00 RMB in debt repayment during Q3 2022, compared to 22,000,000.00 RMB in Q3 2021[27] Shareholder Information - The company has a total of 3,837 common shareholders as of the reporting date[12] - The top shareholder, Ningbo Ruijifu Technology Center, holds 19.31% of the shares, totaling 14,672,272 shares[12] Risks and Challenges - The company faces a risk of delisting if the net profit remains negative and operating revenue falls below RMB 100 million[15] - There is a potential risk of further losses if customer retention and new business development do not meet expectations[15] - The company experienced a 78.51% decline in operating revenue for the year-to-date compared to the same period last year[10] - The total assets at the end of the reporting period were ¥757,453,842.33, a decrease of 4.75% from the end of the previous year[6] - Total assets decreased to CNY 757,453,842.33 in Q3 2022 from CNY 795,255,000.45 in Q3 2021[20] - Total liabilities increased to CNY 150,588,063.77 in Q3 2022, compared to CNY 116,614,900.83 in Q3 2021[19] - Accounts receivable decreased to RMB 156.79 million from RMB 187.14 million year-over-year, indicating potential issues with cash flow[17] - Cash and cash equivalents decreased significantly, impacting liquidity and operational flexibility[19] - The company reported a significant increase in short-term borrowings, rising to CNY 70,674,959.11 in Q3 2022 from CNY 40,035,724.92 in Q3 2021[19] Earnings Per Share - The basic earnings per share for the quarter was -¥0.27, a decline of 195.54% compared to the same period last year[6] - Basic and diluted earnings per share for Q3 2022 were both -0.84 RMB, down from 0.83 RMB in Q3 2021[23]